Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma, Ewing × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Obesity 3 Melanoma 3 Urinary Bladder Neoplasms 2 Neoplasms 2 Infertility 2 Adenocarcinoma Of Esophagus 2 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Progression-Free Survival 1 Preleukemia 1 Posterior Fossa Ependymal Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Metabolic Diseases 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hyperandrogenism 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Cytopenia 1

Interventions

Temozolomide 6 cabozantinib 3 Vincristine 3 Cyclophosphamide 3 liposomal doxorubicin 2 irinotecan sucrosofate 2 fludarabine 2 Zoledronic Acid 2 Specimen Handling 2 Radiotherapy 2 PM 01183 2 Irinotecan 2 Drug Therapy 2 trilaciclib 1 talazoparib 1 silmitasertib 1 romiplostim 1 regorafenib 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 naxitamab 1 fluzoparib 1 fludarabine phosphate 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Triptorelin Pamoate 1 Topotecan 1 Tacrolimus 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡